A novel glucocorticoid receptor (GR) antagonist overcomes GR-mediated chemoresistance in triple negative breast cancer. Jahchan N, Zhou H, Jackson E, Fantin VR et al. Poster session presented at: American Academy for Cancer Research Annual Meeting; 2018 April 14 – 18; Chicago, Illinois, USA.
Development of murine models to evaluate the impact of glucocorticoid receptor (GR) inhibition on chemotherapy response. Jahchan N, Fantin VF et al. Poster session presented at AACR-NCI-EORTC International Conference: Molecular Targets and Cancer Therapeutics; October 26-30, 2017; Philadelphia, PA.
Activation of AR signaling by Mifepristone enhances prostate cancer growth and impairs enzalutamide response. Zhang H, Jahchan N et al. Poster session presented at: American Academy for Cancer Research Annual Meeting; 2017 April 1-5; Washington, D.C., USA.